Literature DB >> 35188640

Machine Learning Models for Predicting Liver Toxicity.

Jie Liu1, Wenjing Guo1, Sugunadevi Sakkiah1, Zuowei Ji1, Gokhan Yavas1, Wen Zou1, Minjun Chen1, Weida Tong1, Tucker A Patterson1, Huixiao Hong2.   

Abstract

Liver toxicity is a major adverse drug reaction that accounts for drug failure in clinical trials and withdrawal from the market. Therefore, predicting potential liver toxicity at an early stage in drug discovery is crucial to reduce costs and the potential for drug failure. However, current in vivo animal toxicity testing is very expensive and time consuming. As an alternative approach, various machine learning models have been developed to predict potential liver toxicity in humans. This chapter reviews current advances in the development and application of machine learning models for prediction of potential liver toxicity in humans and discusses possible improvements to liver toxicity prediction.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Drug development; Liver toxicity; Machine learning; Model; Prediction

Mesh:

Year:  2022        PMID: 35188640     DOI: 10.1007/978-1-0716-1960-5_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  95 in total

Review 1.  Drug repositioning: identifying and developing new uses for existing drugs.

Authors:  Ted T Ashburn; Karl B Thor
Journal:  Nat Rev Drug Discov       Date:  2004-08       Impact factor: 84.694

Review 2.  How to improve R&D productivity: the pharmaceutical industry's grand challenge.

Authors:  Steven M Paul; Daniel S Mytelka; Christopher T Dunwiddie; Charles C Persinger; Bernard H Munos; Stacy R Lindborg; Aaron L Schacht
Journal:  Nat Rev Drug Discov       Date:  2010-02-19       Impact factor: 84.694

Review 3.  Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.

Authors:  Russell A Wilke; Debbie W Lin; Dan M Roden; Paul B Watkins; David Flockhart; Issam Zineh; Kathleen M Giacomini; Ronald M Krauss
Journal:  Nat Rev Drug Discov       Date:  2007-11       Impact factor: 84.694

Review 4.  The current state of serum biomarkers of hepatotoxicity.

Authors:  Josef Ozer; Marcia Ratner; Martin Shaw; Wendy Bailey; Shelli Schomaker
Journal:  Toxicology       Date:  2007-12-05       Impact factor: 4.221

Review 5.  Drug-induced liver injury and drug development: industry perspective.

Authors:  Arie Regev
Journal:  Semin Liver Dis       Date:  2014-05-31       Impact factor: 6.115

Review 6.  Idiosyncratic drug hepatotoxicity: strategy for prevention and proposed mechanism.

Authors:  Toshihiko Ikeda
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 7.  Systematic reviews of animal experiments demonstrate poor human clinical and toxicological utility.

Authors:  Andrew Knight
Journal:  Altern Lab Anim       Date:  2007-12       Impact factor: 1.303

8.  A New Structure-Activity Relationship (SAR) Model for Predicting Drug-Induced Liver Injury, Based on Statistical and Expert-Based Structural Alerts.

Authors:  Fabiola Pizzo; Anna Lombardo; Alberto Manganaro; Emilio Benfenati
Journal:  Front Pharmacol       Date:  2016-11-22       Impact factor: 5.810

Review 9.  Current concepts of mechanisms in drug-induced hepatotoxicity.

Authors:  Stefan Russmann; Gerd A Kullak-Ublick; Ignazio Grattagliano
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

10.  Strategic focus on 3R principles reveals major reductions in the use of animals in pharmaceutical toxicity testing.

Authors:  Elin Törnqvist; Anita Annas; Britta Granath; Elisabeth Jalkesten; Ian Cotgreave; Mattias Öberg
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.